Lexington, MA, United States of America

Tianxiao Sun

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ge Healthcare Bio-Sciences Corp.. Active years: 2016-2017.


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Tianxiao Sun

Introduction

Tianxiao Sun is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biotechnology, particularly in vaccine stabilization. With a total of 2 patents, his work is recognized for its potential impact on public health.

Latest Patents

One of Tianxiao Sun's latest patents focuses on a vaccine stabilizer. This formulation is designed to enhance the thermostability and shelf-life of biological products. It comprises a tertiary amine N-oxide or a derivative, an inorganic salt, glutamic acid or a salt thereof, a polyol, a physiologically acceptable buffer, and a pharmaceutically acceptable carrier. The tertiary amine N-oxide may include trimethylamine-N-oxide, represented by the formula (CH)NO. This innovative formulation is particularly useful for stabilizing vaccines.

Career Highlights

Tianxiao Sun is currently employed at GE Healthcare Bio-Sciences Corp. His work at this company has allowed him to focus on developing solutions that enhance the effectiveness of vaccines. His contributions are vital in addressing challenges in vaccine storage and distribution.

Collaborations

Some of his notable coworkers include Philip M. Levesque and Alicja T. Brown. Their collaborative efforts contribute to the advancement of research and development in the field of biotechnology.

Conclusion

Tianxiao Sun's innovations in vaccine stabilization demonstrate his commitment to improving public health through biotechnology. His work continues to pave the way for advancements in vaccine technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…